# FDA Inspection 1222301 - Sucampo Pharma, LLC - September 27, 2023

Source: https://www.globalkeysolutions.net/records/fda_inspections/sucampo-pharma-llc/bf0a2728-002f-403d-bdb8-13d0fc710a07/
Source feed: FDA_Inspections

> FDA Inspection 1222301 for Sucampo Pharma, LLC on September 27, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1222301
- Company Name: Sucampo Pharma, LLC
- Inspection Date: 2023-09-27
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 954571 - 2015-12-16](https://www.globalkeysolutions.net/api/records/fda_inspections/sucampo-pharma-llc/74033f86-d598-46b6-90c5-63a58f7e8045/)
- [FDA Inspection 738666 - 2011-07-29](https://www.globalkeysolutions.net/api/records/fda_inspections/sucampo-pharma-llc/a4444b74-aef1-475b-b98b-4de0c3efd3c6/)

Company: https://www.globalkeysolutions.net/companies/sucampo-pharma-llc/0b5bf906-e2c7-4686-90c6-2d9b7c7550f9

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c